SCHEMBL5333161

SCHEMBL5333161

CC(NCC(N)=O)S(=O)(=O)O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
CA14 Q9ULX7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28282167 0.78 ALDH1A1 (0.32)
SCHEMBL11520683 0.77
SCHEMBL1378572 0.74
SCHEMBL28387464 0.72 GRIA1 (0.36) CA14
SCHEMBL66202 0.72
Hydrochloric Acid SCHEMBL5724130 0.72
SCHEMBL16351246 0.72
SCHEMBL3705144 0.72
SCHEMBL148567 0.71 GABRR1 (0.33)
SCHEMBL26981439 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590955-B2 Methods and systems for processing particles ZEON CORPORATION (JP) 2026-03-31 US disclosed
US-20230280261-A1 ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES ZEON CORPORATION (JP) 2023-09-07 US disclosed
CN-110186835-B On-chip microfluidic processing of particles GPB科学有限公司 2022-05-31 CN disclosed
EP-3174976-A1 METHODS AND SYSTEMS FOR PROCESSING PARTICLES GPB Scientific, LLC (US) 2017-06-07 EP disclosed
WO-2016019393-A1 METHODS AND SYSTEMS FOR PROCESSING PARTICLES GPB SCIENTIFIC, LLC (US) 2016-02-04 WO disclosed
EP-2971287-A2 ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES GPB Scientific, LLC (US) 2016-01-20 EP disclosed
WO-2014145152-A2 ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES GPB SCIENTIFIC, LLC (US) 2014-09-18 WO disclosed
WO-2007149343-A2 PROTEASES FOR TREATMENT OF VENOMOUS BITES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2007-12-27 WO disclosed
US-20040102564-A1 Method for producing thermoplastic molding materials containing rubber BASF AKTIENGESELLSCHAFT (DE) 2004-05-27 US disclosed
US-5462590-A Stable pH during storage FUJI XEROX CO., LTD. (JP) 1995-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590955-B2 Methods and systems for processing particles EZR, CD47, CD44 MAOA 4611/4885MAOB 4432/4885CA14 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.